BioCentury | May 19, 2020
Finance

May 19 Quick Takes: Cowen closes $493M fund; plus Guangzhou BeBetter, Fountain Therapeutics, Amplyx, ChromaCode, Applied Molecular

...also saw participation from existing investors Northpond Ventures, New Enterprise Associates, Domain Associates, Windham Ventures, Okapi...
BioCentury | Jan 19, 2015
Financial News

Obalon Therapeutics completes venture financing

...& Bros.; Mirae Asset Venture Investment; NeoPlux; Striker Asia Opportunities Fund; Domain Associates; InterWest Partners; Okapi...
BioCentury | Jan 13, 2014
Company News

Aratana, Okapi deal

...Aratana acquired fellow veterinary medicine company Okapi for about €10.3 million ($14 million) in cash and...
...a €11 million ($15 million) promissory note due Dec. 31. Aratana also agreed to pay Okapi...
...€12 million ($16.3 million) in cash or shares of Aratana common stock within 90 days. Okapi...
BioCentury | Nov 21, 2011
Company News

Biocartis board of directors update

...Debiopharm; Alex Dittmair, investment advisor at Valiance; Staf Van Reet, chairman of Actogenix N.V. and Okapi Sciences N.V....
BioCentury | Sep 28, 2009
Emerging Company Profile

Helixis: Running Hot and Cold

...Number of employees: 22 Funds raised: $10 million Investors: Domain Associates, Advanced Technology Ventures and Okapi...
BioCentury | Sep 3, 2007
Company News

Helixis board of directors update

...Diagnostic, Infectious Appointed: Jim Blair, partner at Domain Associates; and Sharon Stevenson, managing director at Okapi...
BioCentury | Aug 30, 2007
Financial News

Helixis raises $10 million

...Carlsbad, Calif.) raised $10 million in a series A round led by Domain Associates and Okapi...
...of photonics company Luxtera (Carlsbad, Calif.), is Helixis' president and CEO. Domain's Jim Blair and Okapi's...
Items per page:
1 - 7 of 7
BioCentury | May 19, 2020
Finance

May 19 Quick Takes: Cowen closes $493M fund; plus Guangzhou BeBetter, Fountain Therapeutics, Amplyx, ChromaCode, Applied Molecular

...also saw participation from existing investors Northpond Ventures, New Enterprise Associates, Domain Associates, Windham Ventures, Okapi...
BioCentury | Jan 19, 2015
Financial News

Obalon Therapeutics completes venture financing

...& Bros.; Mirae Asset Venture Investment; NeoPlux; Striker Asia Opportunities Fund; Domain Associates; InterWest Partners; Okapi...
BioCentury | Jan 13, 2014
Company News

Aratana, Okapi deal

...Aratana acquired fellow veterinary medicine company Okapi for about €10.3 million ($14 million) in cash and...
...a €11 million ($15 million) promissory note due Dec. 31. Aratana also agreed to pay Okapi...
...€12 million ($16.3 million) in cash or shares of Aratana common stock within 90 days. Okapi...
BioCentury | Nov 21, 2011
Company News

Biocartis board of directors update

...Debiopharm; Alex Dittmair, investment advisor at Valiance; Staf Van Reet, chairman of Actogenix N.V. and Okapi Sciences N.V....
BioCentury | Sep 28, 2009
Emerging Company Profile

Helixis: Running Hot and Cold

...Number of employees: 22 Funds raised: $10 million Investors: Domain Associates, Advanced Technology Ventures and Okapi...
BioCentury | Sep 3, 2007
Company News

Helixis board of directors update

...Diagnostic, Infectious Appointed: Jim Blair, partner at Domain Associates; and Sharon Stevenson, managing director at Okapi...
BioCentury | Aug 30, 2007
Financial News

Helixis raises $10 million

...Carlsbad, Calif.) raised $10 million in a series A round led by Domain Associates and Okapi...
...of photonics company Luxtera (Carlsbad, Calif.), is Helixis' president and CEO. Domain's Jim Blair and Okapi's...
Items per page:
1 - 7 of 7